ALYXANDRA YANKASKAS: Open Payments
NPI 1912533910 · PEARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,905 in 245 payments from 24 companies in 2025. Trend: 2023 $4,383 · 2024 $3,716 · 2025 $4,905
Food & beverage: $4,721Education: $184
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $637 |
| GENZYME CORPORATION | 15 | $434 |
| Regeneron Healthcare Solutions, Inc. | 14 | $416 |
| Janssen Biotech, Inc. | 14 | $404 |
| LEO Pharma Inc. | 25 | $352 |
| Galderma Laboratories, L.P. | 17 | $336 |
| Incyte Corporation | 16 | $326 |
| Arcutis Biotherapeutics, Inc. | 20 | $301 |
| UCB, Inc. | 12 | $270 |
| MAYNE PHARMA COMMERCIAL LLC | 16 | $227 |
Products named: DUPIXENT, TREMFYA, ADBRY, OPZELURA, Zoryve, BOTOX, NEMLUVIO, Bimzelx.
Industry payments across TX — which companies pay providers there.
